NCT02542592View on ClinicalTrials.gov

Effect of Methylprednisolone on Immune Signaling in Hip-arthroplasty Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Osteoarthrosis
Interventions
DRUG

Methylprednisolone

Comparison of preoperative single high dose of Methylprednisolone 125 mg iv. and isotonic Sodium Chloride (placebo)

DRUG

Isotonic Sodium Chloride

Placebo

Trial Locations (1)

2400

Copenhagen University Hospital, Bispebjerg, Copenhagen NV

All Listed Sponsors
collaborator

Bispebjerg Hospital

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT02542592 - Effect of Methylprednisolone on Immune Signaling in Hip-arthroplasty Patients | Biotech Hunter | Biotech Hunter